Cytokines, signaling and diseases - a pharmacologist's view.
The International Society for Interferon and Cytokine Research held their meeting Cytokines, Signaling and Diseases in Cairns, Australia, October 26-30, 2003. As there were often parallel sessions, this report discusses selected symposia: STAT as a target for the treatment of cancer, Innate immunity, SOCS and c-CBL: Negative regulation, Tumor immunity, CNS disease, Cellular therapy with adult stem cells and Drug development. There were also a large number of presentations linking the cytokines to cancer and other diseases (e.g., asthma, diabetes), and these are discussed. Presentations considering new therapeutic targets (BAFF, and interleukin-17, -21 and -31) are also considered.
Doggrell
Sheila A
SA
Doggrell Biomedical Communications, Lynfield, Auckland, New Zealand. s_doggrell@yahoo.com
D000022:Abortion, Spontaneous / Q000276:immunology; D000818:Animals; D001249:Asthma / Q000276:immunology; D002493:Central Nervous System Diseases / Q000276:immunology / Q000628:therapy; D016207:Cytokines / Q000378:metabolism*; D003920:Diabetes Mellitus / Q000276:immunology; D007113:Immunity, Innate / Q000502:physiology; D009205:Myocarditis / Q000276:immunology; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D033581:Stem Cell Transplantation
D016207:Cytokines